Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0002043395-26-000016

Chief Medical Officer acquired 3,846 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sayad Pierre Sargis · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-10-12 Grant or award : show line 1 in the form +3,846 $5.53 $21,268 13,533 D
Loading xslF345X06/form4-10132026_041010.xml…